Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-002891
Filing Date
2010-03-30
Accepted
2010-03-29 21:57:48
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2197555z10-k.htm 10-K 1405833
2 EXHIBIT 23.1 a2197555zex-23_1.htm EX-23.1 3892
3 EXHIBIT 31.1 a2197555zex-31_1.htm EX-31.1 7861
4 EXHIBIT 31.2 a2197555zex-31_2.htm EX-31.2 7861
5 EXHIBIT 32.1 a2197555zex-32_1.htm EX-32.1 5634
6 G644854.JPG g644854.jpg GRAPHIC 37668
  Complete submission text file 0001047469-10-002891.txt   1484508
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 (510) 585-2200
ARYx Therapeutics, Inc. (Filer) CIK: 0001410064 (see all company filings)

EIN.: 770456039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33782 | Film No.: 10712085
SIC: 2834 Pharmaceutical Preparations